Karimbayli J, Pellarin I, Belletti B, Baldassarre G
Mol Cancer. 2024; 23(1):135.
PMID: 38951876
PMC: 11218289.
DOI: 10.1186/s12943-024-02043-6.
Ackmann J, Bruge A, Gotina L, Lim S, Jahreis K, Vollbrecht A
Cell Commun Signal. 2024; 22(1):233.
PMID: 38641599
PMC: 11031989.
DOI: 10.1186/s12964-024-01612-y.
Martinez A, Lamaizon C, Valls C, Llambi F, Leal N, Fitzgerald P
Antioxidants (Basel). 2023; 12(11).
PMID: 38001860
PMC: 10669615.
DOI: 10.3390/antiox12112007.
Zuniga N, Dumoulin A, Vaccaro G, Stoeckli E
Development. 2023; 150(19).
PMID: 37747104
PMC: 10617602.
DOI: 10.1242/dev.201671.
Motaln H, Rogelj B
Cells. 2023; 12(16).
PMID: 37626851
PMC: 10453230.
DOI: 10.3390/cells12162041.
expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism.
Hetty S, Vranic M, Kamble P, Lundqvist M, Pereira M, Eriksson J
Adipocyte. 2023; 12(1):2242997.
PMID: 37555665
PMC: 10413912.
DOI: 10.1080/21623945.2023.2242997.
Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association.
Ren J, Cong H, Gao L, Jiang D, Li X, Wang Y
Virulence. 2023; 14(1):2223394.
PMID: 37332205
PMC: 10281466.
DOI: 10.1080/21505594.2023.2223394.
A phylogenetic profiling approach identifies novel ciliogenesis genes in Drosophila and C. elegans.
Dobbelaere J, Su T, Erdi B, Schleiffer A, Dammermann A
EMBO J. 2023; 42(16):e113616.
PMID: 37317646
PMC: 10425847.
DOI: 10.15252/embj.2023113616.
Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials.
Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N
Mol Psychiatry. 2023; 28(6):2197-2214.
PMID: 37264120
PMC: 10611587.
DOI: 10.1038/s41380-023-02113-z.
Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer's disease.
Morshed N, Lee M, Rodriguez F, Lauffenburger D, Mastroeni D, White F
Nat Aging. 2023; 1(6):550-565.
PMID: 37117831
DOI: 10.1038/s43587-021-00071-1.
Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R, Chrysoulaki M, Betsi G, Xekouki P
Medicina (Kaunas). 2023; 59(4).
PMID: 37109772
PMC: 10145673.
DOI: 10.3390/medicina59040812.
c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth.
Chandia-Cristi A, Stuardo N, Trejos C, Leal N, Urrutia D, Bronfman F
Int J Mol Sci. 2023; 24(3).
PMID: 36768268
PMC: 9916151.
DOI: 10.3390/ijms24031944.
New Monoterpenoid Indole Alkaloids from Inhibit -Amyloid42 Production and Phospho-Tau (Thr217).
Li S, Han L, Huang K, Ma Y, Guo L, Guo Y
Int J Mol Sci. 2023; 24(2).
PMID: 36675001
PMC: 9862887.
DOI: 10.3390/ijms24021487.
The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model.
Marin T, Valls C, Jerez C, Huerta T, Elgueta D, Vidal R
IBRO Neurosci Rep. 2023; 13:378-387.
PMID: 36590096
PMC: 9795287.
DOI: 10.1016/j.ibneur.2022.10.006.
Roles for c-Abl in postoperative neurodegeneration.
Feng L, Fu S, Yao Y, Li Y, Xu L, Zhao Y
Int J Med Sci. 2022; 19(12):1753-1761.
PMID: 36313229
PMC: 9608039.
DOI: 10.7150/ijms.73740.
c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases.
Gutierrez D, Chandia-Cristi A, Yanez M, Zanlungo S, Alvarez A
Neural Regen Res. 2022; 18(2):237-243.
PMID: 35900397
PMC: 9396477.
DOI: 10.4103/1673-5374.346540.
Ubiquitin ligase activity inhibits Cdk5 to control axon termination.
Desbois M, Opperman K, Amezquita J, Gaglio G, Crawley O, Grill B
PLoS Genet. 2022; 18(4):e1010152.
PMID: 35421092
PMC: 9041834.
DOI: 10.1371/journal.pgen.1010152.
Epigenomic and Transcriptomic Prioritization of Candidate Obesity-Risk Regulatory GWAS SNPs.
Zhang X, Li T, Xiao H, Ehrlich K, Shen H, Deng H
Int J Mol Sci. 2022; 23(3).
PMID: 35163195
PMC: 8836216.
DOI: 10.3390/ijms23031271.
Post-translational modifications of CDK5 and their biological roles in cancer.
Gao G, Sun Y, Fang R, Wang Y, Wang Y, He Q
Mol Biomed. 2022; 2(1):22.
PMID: 35006426
PMC: 8607427.
DOI: 10.1186/s43556-021-00029-0.
Therapeutic Mechanism and Key Alkaloids of in Alzheimer's Disease From the Perspective of Pathophysiological Processes.
Zeng P, Su H, Ye C, Qiu S, Tian Q
Front Pharmacol. 2022; 12:806984.
PMID: 34975502
PMC: 8715940.
DOI: 10.3389/fphar.2021.806984.